{
  "id": 102938,
  "name": "AMGEN USA INC.",
  "slug": "amgen-usa-inc",
  "state": "CA",
  "description": "Human Therapeutics/Biotechnology firm.",
  "totalSpending": 1400000,
  "filings": 28,
  "yearlySpending": [
    {
      "year": 2018,
      "income": 200000
    },
    {
      "year": 2019,
      "income": 150000
    },
    {
      "year": 2020,
      "income": 150000
    },
    {
      "year": 2021,
      "income": 150000
    },
    {
      "year": 2022,
      "income": 200000
    },
    {
      "year": 2023,
      "income": 200000
    },
    {
      "year": 2024,
      "income": 200000
    },
    {
      "year": 2025,
      "income": 150000
    }
  ],
  "firms": [
    "ACG ADVOCACY"
  ],
  "lobbyists": [
    "MANUS COONEY"
  ],
  "issues": [
    "CPT",
    null
  ],
  "sampleDescriptions": [
    "Patent policy.\nAmerica Invents Act implementation and related legislation.\nUSPTO funding and oversight.",
    "Patent policy.\nUSPTO funding and oversight.",
    "Patent Policy.",
    "Patent policy."
  ],
  "years": [
    2018,
    2019,
    2020,
    2021,
    2022,
    2023,
    2024,
    2025
  ],
  "growthRate": -25,
  "trajectory": "reducing",
  "yearsActive": 8,
  "avgAnnualSpending": 175000,
  "peakYear": 2018,
  "lobbyistCount": 1,
  "firmCount": 1,
  "issueCount": 1
}